PCR047: Patient-centered home cancer screening attitudes during SARS-CoV-2 pandemic

Christelle El Khoury, MD; Elizabeth Haro, MPH; Martha Alves, MPH, MSW; Marie Claire O'Dwyer, MBChB, MPH, NCMP; Kaitlin Meixner, MD; Laura Crespo Albiac; Juana Nicoll Capizzano, MD; Cullen Salada, MD; Sherri Sheinfeld Gorin, PhD, FSBM; Masahito Jimbo, MD, PhD, MPH; Diane Harper, MD, MPH, MS

Abstract

COVID-19 has caused disruptions in health care, in particular cancer screenings. The primary aim of our work was to evaluate the degree to which populations were accepting of home-based screenings for colorectal cancer (CRC) and cervical cancer (primary HPV testing). Three groups of adults having distinct health burdens which may affect acceptance of home-based cancer screening were identified through outpatient electronic medical records as follows as either having survived a COVID hospitalization, having been positive for non-COVID respiratory illness or having type 2 diabetes. 132 respondents (58% female) completed an online survey with hypothetical cases about their acceptance of home-based CRC or cervical cancer screening. Among females, urine and vaginal screening for primary HPV testing was acceptable to 64% and 59%, respectively. Among both males and females, CRC home screening with fecal immunochemical test (FIT) or Cologuard ® was acceptable to 60% of the respondents. When adjusting for education, women with a positive attitude toward home-based urine /vaginal screening were 49 times and 23 times more likely to have a positive attitude toward CRC screening (aOR=48.7 (95% CI: 7.1, 337) and aOR=23.2 (95% CI: 3.8, 142), respectively). This report indicates that home-based cancer screens for CRC and primary HPV testing are acceptable to men and women and may allow for greater compliance with screening in the future.
Leave a Comment
Jack Westfall
jwestfall@aafp.org 11/20/2021

This is a great topic and research study. Nice work. Thanks

Diane Harper
harperdi@med.umich.edu 11/21/2021

Proud of the team. Publication is next in line!

Gillian Bartlett
gillian.bartlett@health.missouri.edu 11/23/2021

Make sure you publicize on NAPCRG Connect - I very much want to read this!

Ann Macaulay
ann.macaulay@mcgill.ca 11/22/2021

Very important questions. Unfortunate low response rate

Gillian Bartlett
gillian.bartlett@health.missouri.edu 11/23/2021

So glad to see this work - many of us are very concerned that preventative health measures, including cancer screening, have been neglected during the pandemic so this is much needed insight.

Andy Pasternak
avpiv711@sbcglobal.net 11/28/2021

Good work on this- as a a family doc, I've already started to see some of the downsides to our actions during the pandemic. We need to find creative solutions to keep people COVID free but make sure they get their regular health care

Social Media

Address

NAPCRG
11400 Tomahawk Creek Parkway
Leawood, KS 66211
800.274.7928
Email: napcrgoffice@napcrg.org